These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38872202)

  • 1. The new framework of innovation biosphere for analysing innovation policies facing COVID-19 grand challenge.
    Nasri S; Fatemi M; Nazeri N; Ghazinoory S
    Health Res Policy Syst; 2024 Jun; 22(1):69. PubMed ID: 38872202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 pandemic: a time for collaboration and a unified global health front.
    Vervoort D; Ma X; Luc JGY
    Int J Qual Health Care; 2021 Mar; 33(1):. PubMed ID: 32592480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing responsible innovation in health: a policy-oriented framework.
    Pacifico Silva H; Lehoux P; Miller FA; Denis JL
    Health Res Policy Syst; 2018 Sep; 16(1):90. PubMed ID: 30200985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best Practice Guidance for Creation and Management of Innovations in Health care and Information and Communications Technologies.
    Schee Genannt Halfmann S; Evangelatos N; Kweyu E; van der Merwe A; Steinhausen K; Brand A
    OMICS; 2022 Feb; 26(2):106-114. PubMed ID: 34495756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Is a Crisis in Planetary Health and Politics of Expertise: Time to Think Critically and Innovate Both.
    Boschele M
    OMICS; 2021 May; 25(5):279-284. PubMed ID: 33961517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing COVID-19 within and across health systems: why we need performance intelligence to coordinate a global response.
    Kringos D; Carinci F; Barbazza E; Bos V; Gilmore K; Groene O; Gulácsi L; Ivankovic D; Jansen T; Johnsen SP; de Lusignan S; Mainz J; Nuti S; Klazinga N;
    Health Res Policy Syst; 2020 Jul; 18(1):80. PubMed ID: 32664985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysing the performance of a health innovation ecosystem in the COVID-19 crisis: complexity and chaos theory perspective.
    Moeenian M; Ghazinoory S; Yaghmaie P
    Health Res Policy Syst; 2024 May; 22(1):59. PubMed ID: 38773524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare leaders' use of innovative solutions to ensure resilience in healthcare during the Covid-19 pandemic: a qualitative study in Norwegian nursing homes and home care services.
    Lyng HB; Ree E; Wibe T; Wiig S
    BMC Health Serv Res; 2021 Aug; 21(1):878. PubMed ID: 34446000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Digital Health Innovation Policy: A Portal to Alternative Futures in the Making.
    Bayram M; Springer S; Garvey CK; Özdemir V
    OMICS; 2020 Aug; 24(8):460-469. PubMed ID: 32511054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policies for life sciences and healthcare in the global health framework.
    Huttin CC
    Technol Health Care; 2023; 31(4):1497-1504. PubMed ID: 36847031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rise and fall of global health issues: an arenas model applied to the COVID-19 pandemic shock.
    Smith SL; Shiffman J; Shawar YR; Shroff ZC
    Global Health; 2021 Mar; 17(1):33. PubMed ID: 33781272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MULTI-ACT model: the path forward for participatory and anticipatory governance in health research and care.
    Zaratin P; Bertorello D; Guglielmino R; Devigili D; Brichetto G; Tageo V; Dati G; Kramer S; Battaglia MA; Di Luca M
    Health Res Policy Syst; 2022 Feb; 20(1):22. PubMed ID: 35177080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative Evolution of China's Excellent Innovative Research Groups from the Perspective of Innovation Ecosystem: Taking an "Environmental Biogeochemistry" Research Innovation Group as a Case Study.
    Gao J; Liu S; Li Z
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Narrative Review of Innovative Responses During the COVID-19 Pandemic in 2020.
    Wu TC; Ho CB
    Int J Public Health; 2022; 67():1604652. PubMed ID: 36570874
    [No Abstract]   [Full Text] [Related]  

  • 15. Reimagining Innovation Amid the COVID-19 Pandemic: Insights From the WISH Innovation Programme.
    El Akoum M; El Achi M
    Front Public Health; 2021; 9():678768. PubMed ID: 34164373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conceptual framework for analysing partnership and synergy in a global health alliance: case of the UK Public Health Rapid Support Team.
    Raftery P; Hossain M; Palmer J
    Health Policy Plan; 2022 Mar; 37(3):322-336. PubMed ID: 34919688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response and innovations of advanced practice nurses during the COVID-19 pandemic: A scoping review.
    Ziegler E; Martin-Misener R; Rietkoetter S; Baumann A; Bougeault IL; Kovacevic N; Miller M; Moseley J; Wong FKY; Bryant-Lukosius D
    Int Nurs Rev; 2024 Jun; 71(2):250-275. PubMed ID: 37737005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Leadership in Public Sector Innovation: A Systematic Review and Meta-Analysis of the Management of COVID-19 in Asian Countries.
    Sazzad F; Rajan VP; Demircioglu MA
    Front Public Health; 2021; 9():743748. PubMed ID: 34976914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Pandemic as an Excellent Opportunity for Global Health Diplomacy.
    Taghizade S; Chattu VK; Jaafaripooyan E; Kevany S
    Front Public Health; 2021; 9():655021. PubMed ID: 34322467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Framework for Improving Policy Priorities in Managing COVID-19 Challenges in Developing Countries.
    Rasul G
    Front Public Health; 2020; 8():589681. PubMed ID: 33154960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.